Patient-derived anti-β2GP1 antibodies recognize a peptide motif pattern and not a specific sequence of residues.

Published on Aug 1, 2017in Haematologica7.116
· DOI :10.3324/HAEMATOL.2017.170381
Philippe de Moerloose44
Estimated H-index: 44
Céline Fickentscher5
Estimated H-index: 5
+ 3 AuthorsKarim J. Brandt12
Estimated H-index: 12
Antiphospholipid antibody syndrome is an autoimmune disease characterized by the presence of so-called antiphospholipid antibodies and clinical manifestations such as recurrent thromboembolic or pregnancy complications. Although the main antigenic determinant for antiphospholipid antibodies has been identified as the β-2-glycoprotein 1 (β2GP1), the precise epitope recognized by antiphospholipid antibodies still remains largely unknown. In the study herein, we wanted to identify a sequence in domain I of β2GP1 able to induce the proliferation of CD4+ T cells isolated from antiphospholipid antibody syndrome patients, but not from healthy donors, and to interact with antiphospholipid antibodies. We have characterized a sequence in domain I of β2GP1 that triggers CD4+ T-cell proliferation. A comparison of this sequence with the previously reported binding of antiphospholipid antibodies to discontinuous epitope R39-R43 reveals the presence of an indeterminate motif in β2GP1, in which the polarity determines the characteristics and specificity of antiphospholipid antibodies-interacting motifs. Using point mutations, we characterized the main antiphospholipid antibodies-interacting motif as ϕϕϕζζFxC, but also established ϕϕϕζζFxϕ-related motifs as potential antiphospholipid antibodies epitopes, in which ϕ represents nonpolar residues and ζ polar residues, with charges of the residues not being involved. Of specific importance, these different motifs are present at least once in all antiphospholipid antibodies-related receptors described so far. We have further demonstrated, in vitro, that peptides and domains of β2GP1 containing these motifs were able to interact with antiphospholipid antibodies and inhibit their monocyte activating activity. These results established that the antiphospholipid antibodies-interacting motifs are determined by the polarity, but not by the sequence or charge, of amino acids. These data could also contribute to the future development of more sensitive and specific diagnostic tools for antiphospholipid antibody syndrome determination and potential peptide- or β2GP1 domain-based clinical therapies.
📖 Papers frequently viewed together
22 Citations
4,748 Citations
121 Citations
#1Noha Abdel-WahabH-Index: 14
#2Maria A. Lopez-Olivo (University of Texas MD Anderson Cancer Center)H-Index: 32
Last. Maria E. Suarez-Almazor (University of Texas MD Anderson Cancer Center)H-Index: 77
view all 4 authors...
ObjectiveThe objective of this study was to conduct a systematic review of case reports documenting the development of antiphospholipid syndrome or antiphospholipid syndrome-related features after an infection.MethodsWe searched Medline, EMBASE, Web of Science, PubMed ePubs, and The Cochrane Library – CENTRAL through March 2015 without restrictions. Studies reporting cases of antiphospholipid syndrome or antiphospholipid syndrome-related features following an infection were included.ResultsTwo h...
57 CitationsSource
#1Kenji Tanimura (Kobe University)H-Index: 13
#2Hui Jin (Osaka University)H-Index: 6
Last. Hisashi Arase (Osaka University)H-Index: 57
view all 20 authors...
Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by thrombosis and/or pregnancy complications. β2-glycoprotein I (β2GPI) complexed with phospholipid is recognized as a major target for autoantibodies in APS; however, less than half the patients with clinical manifestations of APS possess autoantibodies against the complexes. Therefore, the range of autoantigens involved in APS remains unclear. Recently, we found that human leukocyte antigen (HLA) class II molecules transpo...
39 CitationsSource
#1Laura Cousins (UCL: University College London)H-Index: 1
#2Charis Pericleous (UCL: University College London)H-Index: 15
Last. Anisur Rahman (UCL: University College London)H-Index: 68
view all 7 authors...
The standard serological tests included in the classification criteria1 for antiphospholipid syndrome (APS) are those to detect immunoglobulin G (IgG) and IgM antibodies to cardiolipin (aCL) or β-2-glycoprotein I (anti-β2GPI) and the lupus anticoagulant. It is increasingly recognised, however, that some patients have typical thrombotic and non-thrombotic features of APS but test repeatedly negative in these routinely used assays. It has been suggested that these patients have the so-called seron...
35 CitationsSource
The antiphospholipid antibody syndrome (APS) is an autoimmune disease associated with arterial or venous thrombosis and/or recurrent fetal loss and is caused by pathogenic antiphospholipid antibodies (aPLA). We recently demonstrated that Toll-like receptor 2 (TLR2) and CD14 contribute to monocyte activation of aPLA.
35 CitationsSource
#1Karim J. BrandtH-Index: 12
Last. Philippe de MoerlooseH-Index: 44
view all 3 authors...
Abstract The antiphospholipid syndrome (APS) is an autoimmune disease associated with arterial or venous thrombosis and/or recurrent fetal loss and is caused by pathogenic antiphospholipid antibodies (aPLA). The plasma protein β2-glycoprotein 1 (β2GP1) has been identified as a major target of aPLA associated with APS. Cell activation by aPLA appears to be a major pathogenic cause in the pathogenesis of APS. Receptors, co-receptors and accessory molecules are known to assist the pathogenic effect...
28 CitationsSource
#1Melonie L DurkinH-Index: 1
#2Diana L. Marchese (FSU: Florida State University)H-Index: 3
Last. Moti RamgopalH-Index: 3
view all 4 authors...
Catastrophic antiphospholipid syndrome (CAPS) has been associated with several bacterial and viral infections. We presented a case report of a woman who presented to the emergency room, with influenza A virus subtype H1N1 which progressed to CAPS in the course of 17 days. We believe this is the first case that links CAPS with H1N1.
13 CitationsSource
The antiphospholipid syndrome is a prothrombotic disorder associated with autoantibodies. It is associated with obstetrical complications (mainly spontaneous abortion) as well as venous and arterial thrombotic risks. Insights into disease mechanisms have led to new therapies.
442 CitationsSource
#1Saakshi Khattri (Albert Einstein College of Medicine)H-Index: 16
#2Gisele Zandman-Goddard (Wolfson Medical Center)H-Index: 56
Last. Elena Peeva (Albert Einstein College of Medicine)H-Index: 18
view all 3 authors...
Abstract The increased awareness of the role of humoral immunophysiology in antiphospholipid syndrome (APS) has aroused interest in B cells as therapeutic targets in this disease. This paper reviews the literature on B cell directed therapies in human and experimental APS. The clinical data is limited to B cell depletion with rituximab and comprises case reports and case series. Murine studies include use of modulators of B cell function such as belimumab and abatacept. In both human and murine ...
52 CitationsSource
#1Urška ŽagerH-Index: 3
#2Mojca LunderH-Index: 18
Last. Borut BožičH-Index: 12
view all 7 authors...
β2-glycoprotein I (β2GPI) is a major autoantigen of autoimmune thrombophilia, known as the antiphospholipid syndrome. The exact mechanism underlying the β2GPI’s involvement in the disease is not fully elucidated, as it is not its physiological role. We used random phage peptide library to identify sequences binding to β2GPI. Obtained K(L/V)WX(I/L/V)P motif, primarily designated as target unrelated, was confirmed as the selective binder of β2GPI. Based on this motif we confirmed the previously su...
3 Citations
#1Bas de Laat (UU: Utrecht University)H-Index: 24
#2Miranda E.A.T. van Berkel (UU: Utrecht University)H-Index: 4
Last. Coen Maas (UU: Utrecht University)H-Index: 26
view all 7 authors...
Objective The presence of autoantibodies against a cryptic epitope in domain I of β2-glycoprotein I (β2GPI) is strongly associated with thrombotic events in patients with the antiphospholipid syndrome. We hypothesized that a conformational change could be a trigger for the formation of antibodies against domain I of β2GPI. Therefore, we investigated whether immune responses against β2GPI are related to its conformation. Methods Conformational changes in β2GPI were studied using various technique...
74 CitationsSource
Cited By8
#1Stéphane ZuilyH-Index: 9
#2Bas de Laat (UM: Maastricht University)H-Index: 24
Last. Denis WahlH-Index: 28
view all 18 authors...
BACKGROUND Antibodies binding to domain I of β2-glycoprotein I (aDI) and activated protein C (APC) resistance are associated with an increased risk of thrombosis in cross-sectional studies. The objective of this study was to assess their predictive value for future thromboembolic events in patients with antiphospholipid antibodies (aPL) or antiphospholipid syndrome. METHODS This prospective multicenter cohort study included consecutive patients with aPL or systemic lupus erythematosus. We follow...
4 CitationsSource
#1Maurizio Sorice (Sapienza University of Rome)H-Index: 45
#2Roberta Misasi (Sapienza University of Rome)H-Index: 32
#1Guilherme Ramires de Jesus (UERJ: Rio de Janeiro State University)H-Index: 9
#2Ashley E. Benson (UofU: University of Utah)H-Index: 2
Last. D.W. Branch (UofU: University of Utah)H-Index: 26
view all 5 authors...
Obstetric antiphospholipid syndrome (APS) remains a clinical challenge for practitioners, with several controversial points that have not been answered so far. This Obstetric APS Task Force met on ...
6 CitationsSource
#1David Salem (MUHC: McGill University Health Centre)H-Index: 4
#2Rebecca Subang (MUHC: McGill University Health Centre)H-Index: 12
Last. Joyce Rauch (MUHC: McGill University Health Centre)H-Index: 37
view all 5 authors...
Systemic lupus erythematosus is a prototypic model for B-cell epitope spread in autoimmunity. Autoantibodies to numerous molecularly distinct self-antigens emerge in a sequential manner over several years, leading to disease manifestations. Among the earliest autoantibodies to appear are those targeting phospholipid-binding proteins, particularly β2-glycoprotein I. Notably, mice immunized with β2-glycoprotein I and lipopolysaccharide develop a strong T cell response to β2-glycoprotein I that is ...
8 CitationsSource
#1Karl J. Lackner (University of Mainz)H-Index: 64
#2Nadine Müller-Calleja (University of Mainz)H-Index: 1
ABSTRACTIntroduction: Even though our understanding of the antiphospholipid syndrome (APS) has improved tremendously over the last decades, we are still not in a position to replace symptomatic anticoagulation by pathogenesis based causal treatments.Areas covered: Recent years have provided further insights into pathogenetically relevant mechanisms. These include a differentiation of pathogenic subtypes of antiphospholipid antibodies (aPL), novel mechanisms modulating disease activity, for examp...
5 CitationsSource
#1Joyce Rauch (MUHC: McGill University Health Centre)H-Index: 37
#2David Salem (MUHC: McGill University Health Centre)H-Index: 4
Last. Jerrold S. Levine (UIC: University of Illinois at Chicago)H-Index: 26
view all 5 authors...
Anti-phospholipid syndrome (APS) and systemic lupus erythematosus (SLE) are autoimmune diseases characterized by autoantibody production and autoantibody-related pathology. Anti-phospholipid antibodies (aPL) are found in all patients with APS and in 20-30% of individuals with SLE. aPL recognize a number of autoantigens, but the primary target in both APS and SLE is β2-glycoprotein I (β2GPI). The production of IgG aPL in APS and SLE, as well as the association of aPL with certain MHC class II mol...
10 CitationsSource
#1James C. Weaver (UNSW: University of New South Wales)H-Index: 9
#2Steven A. Krilis (UNSW: University of New South Wales)H-Index: 62
Last. Bill Giannakopoulos (UNSW: University of New South Wales)H-Index: 18
view all 3 authors...
Abstract The anti-phospholipid syndrome (APS) is a prothrombotic autoimmune disorder characterized by either thrombosis or pregnancy complications in the setting of persistent anti-phospholipid antibodies (aPL). βeta 2-glycoprotein I (β2-GPI) is the major autoantigen in APS that binds anionic phospholipids as well as specific receptors on platelets and endothelial cells resulting in activation of prothrombotic pathways. β2-GPI consists of 5 Domains that exist in a circular or linear form, with t...
6 CitationsSource
Background Antiphospholipid antibodies (aPL) contribute to the pathogenesis of the antiphospholipid syndrome (APS) by induction of an inflammatory and procoagulant state in different cell types and several signaling pathways have been described. Objectives We hypothesized that signaling depends on epitope specificity of aPL. Methods Cellular effects of three human monoclonal aPL with distinctly different epitope specificities were analyzed in vitro. Expression of tumor necrosis factor α mRNA by ...
16 CitationsSource